Glaxo chief apologizes for 'mistakes' that led to U.S. fines

GlaxoSmithKline ($GSK) CEO Andrew Witty admitted that the company made "unacceptable" mistakes in mismarketing the antidepressants Paxil and Wellbutrin, which were the subject of a $3 billion Justice Department settlement earlier this month. Witty said he was "very sorry" and "determined that this is never going to happen again." Report